Pro-Bitcoin Commerce Secretary, BTC swings and new SEC unit — here's what you missed this week
Fidelity integrates Lightning, Fold goes public, SEC fights crypto fraud, and bitcoiner Howard Lutnick is confirmed as U.S.
Trump wants to abolish IRS after tariff revenues make ‘whole economy explode,’ new Commerce secretary Howard Lutnick reveals
President Donald Trump announced a new “External Revenue Service” that would be tasked with collecting revenue from tariffs, ...
Cantor Fitzgerald Cuts NICE (NASDAQ:NICE) Price Target to $161.00
NICE (NASDAQ:NICE – Get Free Report) had its target price reduced by stock analysts at Cantor Fitzgerald from $176.00 to $161 ...
US Commerce Secretary Howard Lutnick's Cantor Fitzgerald Increases Bitcoin Exposure Via ETFs, MSTR, MARA; Adds Chinese Firms Like BABA, Baidu, JD In Q4
US Commerce Secretary Howard Lutnick‘s hedge fund Cantor Fitzgerald LP increased the firm’s exposure to Bitcoin (CRYPTO: BTC) ...
Rivian downgraded by Cantor on weak 2025 delivery outlook
Cantor Fitzgerald downgraded Rivian Automotive (NASDAQ:RIVN) to Neutral from Overweight given a weaker-than-expected 2025 delivery outlook and macroeconomic challenges, including new tariffs and the ...
Tripadvisor (NASDAQ:TRIP) Price Target Lowered to $13.00 at Cantor Fitzgerald
Tripadvisor (NASDAQ:TRIP – Get Free Report) had its target price decreased by stock analysts at Cantor Fitzgerald from $14.00 ...
Rivian 'Long Term Winner' In EV Sector: Analysts Less Optimistic On Short Term With White House Questions
Rivian analysts see a bright long-term future for Rivian with the launch of the R2. Questions remain for 2025.
Nice price target lowered to $161 from $176 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Nice (NICE) to $161 from $176 and keeps a Neutral rating on the shares. Nice reported ...
Lutnick sworn in as Commerce Secretary
Howard Lutnick was sworn in as Secretary of Commerce, adding to the list of President Trump’s Cabinet picks to become ...
Cantor Fitzgerald Reiterates “Overweight” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...